Literature DB >> 32273587

Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients.

Paolo J Fantozzi1,2, Alessandro Villa3, Joseph H Antin4, Nathaniel Treister5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32273587     DOI： 10.1038/s41409-020-0889-2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.

Authors:  Glenn J Hanna; Eric R Kofman; Muhammad Ali Shazib; Sook-Bin Woo; Brendan Reardon; Nathaniel S Treister; Robert I Haddad; Corey S Cutler; Joseph H Antin; Eliezer M Van Allen; Ravindra Uppaluri; Robert J Soiffer
Journal:  Oral Oncol       Date:  2018-04-10       Impact factor: 5.337

2.  Oral proliferative verrucous leukoplakia (PVL) in a post-bone marrow transplant patient.

Authors:  Cassius Torres-Pereira; Vaneuza Funke; Allan F Giovanini; Celso A Lemos; José M Amenabar; Cleto M Piazzetta
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

3.  Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

Authors:  David Miklos; Corey S Cutler; Mukta Arora; Edmund K Waller; Madan Jagasia; Iskra Pusic; Mary E Flowers; Aaron C Logan; Ryotaro Nakamura; Bruce R Blazar; Yunfeng Li; Stephen Chang; Indu Lal; Jason Dubovsky; Danelle F James; Lori Styles; Samantha Jaglowski
Journal:  Blood       Date:  2017-09-18       Impact factor: 22.113

4.  Management of proliferative verrucous leukoplakia: Justification for a conservative approach.

Authors:  Scott C Borgna; Peter T Clarke; Andrew G Schache; Derek Lowe; Michael W Ho; Caroline E McCarthy; Stephen Adair; E Anne Field; John K Field; Deborah Holt; Janet M Risk; Bijay P Rajlawat; Asterios Triantafyllou; Richard J Shaw
Journal:  Head Neck       Date:  2017-06-22       Impact factor: 3.147

5.  Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions.

Authors:  Takahiro Yagyuu; Kinta Hatakeyama; Mitsuhiko Imada; Miyako Kurihara; Yumiko Matsusue; Kazuhiko Yamamoto; Chiho Obayashi; Tadaaki Kirita
Journal:  Oral Oncol       Date:  2017-03-18       Impact factor: 5.337

6.  Proliferative verrucous leukoplakia. A long-term study of thirty patients.

Authors:  L S Hansen; J A Olson; S Silverman
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1985-09

Review 7.  Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

Authors:  J W Mays; H Fassil; D A Edwards; S Z Pavletic; C W Bassim
Journal:  Oral Dis       Date:  2012-10-28       Impact factor: 3.511

8.  Proliferative leukoplakia: Proposed new clinical diagnostic criteria.

Authors:  A Villa; R S Menon; A R Kerr; F De Abreu Alves; A Guollo; D Ojeda; S B Woo
Journal:  Oral Dis       Date:  2018-05-02       Impact factor: 3.511

9.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

10.  Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update.

Authors:  B Mohty; M Mohty
Journal:  Blood Cancer J       Date:  2011-04-29       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.